Welcome. If you're a registered user, please log-in. If not, please sign-up.
Genome Editing Applications Conference

Genome Editing Applications Conference
10 Industry Case Studies
TJ Cradick, Head of Genome Editing, CRISPR Therapeutics, USA
Paul Diehl, Director of Business Development, Cellecta, Inc. USA
Anett Ritter, Postdoctoral Fellow, Novartis, Switzerland
Lorenz Mayr, Vice President & Global Head, Biological Reagents & Assay Development, AstraZeneca, UK
Advanced Academia Applications
Helene Faustrup Kildegaard, Co-Principal Investigator, Technical University of Denmark, Denmark
William C. Skarnes, Senior Group Leader, Wellcome Trust Sanger Institute, UK
Roderick Beijersbergen, Group leader and Head NKI Robotics and Screening Center, The Netherlands Cancer Institute, The Netherlands
Rafael Yáñez-Muñoz, Reader in Advanced Therapy, Royal Holloway-University of London, UK
Accelerate your Therapeutics to Market and Improve Drug Discovery Efficiencies
Uncover Ways to Navigate the IP Landscape of Genome Editing Technologies
Present a Poster

Share your research against leading experts in the field.

Find out more

Poster application deadline: 20 January 2016

Book Your Exhibition Space For 2016

Contact linda.cole@informa.com to book your space now to avoid disappointment 

Therapeutic and Biomedical Applications of CRISPRs, ZFNs, TALENs and other Genome Engineering Technologies

Therapeutic, Drug Discovery & Research Applications of Genome Editing Technologies

Informa's Genome Editing conference will showcase the most up-to-date therapeutic and biomedical applications emerging using CRISPRs, ZFNs, TALENs, AAVs and other genome engineering technologies. From improving lead discovery, validation of targeted cell lines and development of transgenic animal models to therapeutic uses in cell therapy & gene therapy.

A special emphasis on CRISPR will highlight the design of novel CRISPR constructs and discuss practical aspects of CRISPR including monitoring off-target effects, strategies to improve specificity and delivery to specific cell types, including potential applications in multigenic alterations.

By attending this applications focused conference you will learn about advances in all of the latest genome editing technologies and how to position your company for success in genome editing in the face of the still-evolving IP landscape of CRISPR.

Feedback from our USA Genome Editing Event

"Great overview of the field both for (for those) trained and untrained in the art…of genome editing"
Eric Paul Bennett, University of Copenhagen
"A conference not-to-be-missed for anyone actively involved in genome editing or interested in using genome editing technologies"
Inès Royaux, Ph.D., Senior Scientist, Janssen R&D, a division of Janssen Pharmaceuticals NV, Belgium

2016 Speaker Faculty

  • Lorenz Mayr, AstraZeneca, UK

  • TJ Cradick, CRISPR Therapeutics, USA

  • Philippe Duchateau, Cellectis, France

  • Ines Royaux, Janssen R&D, a division of Janssen Pharmaceutica NV, Belgium

  • Myung Shin, Merck & Co., Inc. USA

  • Anett Ritter, Novartis, Switzerland

  • William Skarnes, The Wellcome Trust Sanger Institute, UK

  • Roderick Beijersbergen, The Netherlands Cancer Institute, The Netherlands

  • Helene Faustrup Kildegaard, Technical University of Denmark, Denmark

  • Paul Diehl, Cellecta, Inc., USA

  • Laurakay Bruhn, Agilent Research Labs, USA

  • Victor Dillard, Desktop Genetics, UK

  • Rafael Yáñez-Muñoz, Royal Holloway-University of London, UK
  • Phillip Webber, Dehns (Patent and Trade Mark Attorneys), UK

  • Eric Paul Bennett, University of Copenhagen, Denmark

Dates and Venues

03 Feb 2016 - 04 Feb 2016

Sheraton Brussels Airport Hotel

2016 Sponsors & Exhibitors

2016 Sponsors & Exhibitors
2016 Sponsors & Exhibitors
2016 Sponsors & Exhibitors
2016 Sponsors & Exhibitors

Co-located with

Cell T Logo

Who Should Attend Genome Editing 2015?

Professors, Directors, Managers and Heads, Scientists and Researchers Working in: Drug Discovery Drug Development Research R&D Screening
Target Discovery Target Identification Target Validation Genomics / Genetics Genome Editing / Gene Editing Genome Engineering Genetic Engineering
Functional Genomics Preclinical Early Development Animal Models Translational Medicine Transgenic Sciences Gene Therapy
Rare Diseases Cell Therapy Immunotherapy

Event Countdown


2016 Sponsors & Exhibitors


Promotional Participant


Media Partners


Informa Life Sciences is part of the Knowledge & Networking Division of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.